HeimBiotek Develops COVID-19 Diagnostic Kit Using SBDE™ PCR Technology
HeimBiotek announced that it has successfully developed a diagnostic kit using specific bi-directional extension PCR technology (SBDE™-PCR).
HeimBiotek possesses technology for detecting and analyzing microRNA, a next-generation molecular diagnostic biomarker. The company has completed domestic patent registration for its core technology and is currently in the process of international patent applications in the United States, Europe, Japan, and China.
The company plans to apply for emergency use authorization for its COVID-19 diagnostic kit. HeimBiotek is proceeding with approval procedures from the Korea Disease Control and Prevention Agency (KDCA) and the Ministry of Food and Drug Safety (MFDS), while also pursuing related approvals for international export.
This content is partially excerpted from a news article.
